Minimal important difference of the transition dyspnoea index in a multinational clinical trial
暂无分享,去创建一个
[1] D. Mahler,et al. Meaningful effect size and patterns of response of the transition dyspnea index. , 2003, Journal of clinical epidemiology.
[2] E. Bateman,et al. A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. , 2002, Chest.
[3] P. Jones. Interpreting thresholds for a clinically significant change in health status in asthma and COPD , 2002, European Respiratory Journal.
[4] R. Zuwallack,et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease , 2002, European Respiratory Journal.
[5] J. V. van Noord,et al. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium , 2002, European Respiratory Journal.
[6] R. Pauwels,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.
[7] S. Yancey,et al. Efficacy of salmeterol xinafoate in the treatment of COPD. , 1999, Chest.
[8] Murray D. Altose,et al. Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society. , 1999, American journal of respiratory and critical care medicine.
[9] N. Ambrosino,et al. Long-term effectiveness of pulmonary rehabilitation in patients with chronic airway obstruction. , 1999, The European respiratory journal.
[10] F. Martinez,et al. Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function. , 1997, American journal of respiratory and critical care medicine.
[11] A. Tosteson,et al. Effect of exercise training on dyspnea measures in patients with chronic obstructive pulmonary disease. , 1997, Journal of cardiopulmonary rehabilitation.
[12] G. Guyatt,et al. Assessing the minimal important difference in symptoms: a comparison of two techniques. , 1996, Journal of clinical epidemiology.
[13] D. O’Donnell,et al. The impact of exercise reconditioning on breathlessness in severe chronic airflow limitation. , 1995, American journal of respiratory and critical care medicine.
[14] A. Tosteson,et al. Changes in dyspnea, health status, and lung function in chronic airway disease. , 1995, American journal of respiratory and critical care medicine.
[15] B. Make,et al. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.
[16] R. Kaplan,et al. Reliability and validity of dyspnea measures in patients with obstructive lung disease , 1995, International journal of behavioral medicine.
[17] T. Beroíza,et al. Inspiratory muscle training in chronic airflow limitation: comparison of two different training loads with a threshold device. , 1994, The European respiratory journal.
[18] R. Zuwallack,et al. The effect of comprehensive outpatient pulmonary rehabilitation on dyspnea. , 1994, Chest.
[19] H. Magnussen,et al. Effects of theophylline withdrawal in severe chronic obstructive pulmonary disease. , 1993, Chest.
[20] P. Jones,et al. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. , 1992, The American review of respiratory disease.
[21] C. Sherbourne,et al. The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .
[22] J. A. Daubenspeck,et al. Measurement of respiratory sensation in interstitial lung disease. Evaluation of clinical dyspnea ratings and magnitude scaling. , 1989, Chest.
[23] J. A. Daubenspeck,et al. Targeted inspiratory muscle training improves respiratory muscle function and reduces dyspnea in patients with chronic obstructive pulmonary disease. , 1989, Annals of internal medicine.
[24] A. Gift. Clinical measurement of dyspnea. , 1989, Dimensions of critical care nursing : DCCN.
[25] C K Wells,et al. Evaluation of clinical methods for rating dyspnea. , 1988, Chest.
[26] Mahler Da. Dyspnea: diagnosis and management. , 1987 .
[27] D. Mahler. Dyspnea: diagnosis and management. , 1987, Clinics in chest medicine.
[28] Phillips Yy,et al. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. , 1987, The American review of respiratory disease.
[29] C. Wells,et al. Sustained-release theophylline reduces dyspnea in nonreversible obstructive airway disease. , 2015, The American review of respiratory disease.
[30] R. Gilbert. Sustained-release theophylline reduces dyspnea in nonreversible obstructive airway disease. , 1985, The American review of respiratory disease.
[31] C. Wells,et al. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. , 1984, Chest.